Survival analysis, long-term outcomes, and percentage of recovery up to 8 years post-infection among the Houston West Nile virus cohort - PubMed (original) (raw)
Survival analysis, long-term outcomes, and percentage of recovery up to 8 years post-infection among the Houston West Nile virus cohort
Kristy O Murray et al. PLoS One. 2014.
Abstract
In 2012, we witnessed a resurgence of West Nile virus (WNV) in the United States, with the largest outbreak of human cases reported since 2003. WNV is now endemic and will continue to produce epidemics over time, therefore defining the long-term consequences of WNV infection is critical. Over a period of eight years, we prospectively followed a cohort of 157 WNV-infected subjects in the Houston metropolitan area to observe recovery over time and define the long-term clinical outcomes. We used survival analysis techniques to determine percentage of recovery over time and the effects of demographic and co-morbid conditions on recovery. We found that 40% of study participants continued to experience symptoms related to their WNV infection up to 8 years later. Having a clinical presentation of encephalitis and being over age 50 were significantly associated with prolonged or poor recovery over time. Since the health and economic impact as a result of prolonged recovery, continued morbidity, and related disability is likely substantial in those infected with WNV, future research should be aimed at developing effective vaccines to prevent illness and novel therapeutics to minimize morbidity, mortality, and long-term complications from infection.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
Similar articles
- Use of Testing for West Nile Virus and Other Arboviruses.
Vanichanan J, Salazar L, Wootton SH, Aguilera E, Garcia MN, Murray KO, Hasbun R. Vanichanan J, et al. Emerg Infect Dis. 2016 Sep;22(9):1587-93. doi: 10.3201/eid2209.152050. Emerg Infect Dis. 2016. PMID: 27537988 Free PMC article. - Surveillance for human West Nile virus disease - United States, 1999-2008.
Lindsey NP, Staples JE, Lehman JA, Fischer M; Centers for Disease Control and Prevention (CDC). Lindsey NP, et al. MMWR Surveill Summ. 2010 Apr 2;59(2):1-17. MMWR Surveill Summ. 2010. PMID: 20360671 - West Nile Virus Outbreak in Houston and Harris County, Texas, USA, 2014.
Martinez D, Murray KO, Reyna M, Arafat RR, Gorena R, Shah UA, Debboun M. Martinez D, et al. Emerg Infect Dis. 2017 Aug;23(8):1372-1376. doi: 10.3201/eid2308.170384. Emerg Infect Dis. 2017. PMID: 28726615 Free PMC article. - West Nile virus: should pediatricians care?
Smith JC, Mailman T, MacDonald NE. Smith JC, et al. J Infect. 2014 Nov;69 Suppl 1:S70-6. doi: 10.1016/j.jinf.2014.07.019. Epub 2014 Aug 17. J Infect. 2014. PMID: 25138381 Review. - Epidemiologic and clinical parameters of West Nile virus infections in humans: a scoping review.
Yeung MW, Shing E, Nelder M, Sander B. Yeung MW, et al. BMC Infect Dis. 2017 Sep 6;17(1):609. doi: 10.1186/s12879-017-2637-9. BMC Infect Dis. 2017. PMID: 28877682 Free PMC article. Review.
Cited by
- Keeping T cell memories in mind.
Mix MR, Harty JT. Mix MR, et al. Trends Immunol. 2022 Dec;43(12):1018-1031. doi: 10.1016/j.it.2022.10.001. Epub 2022 Nov 8. Trends Immunol. 2022. PMID: 36369103 Free PMC article. Review. - Use of Testing for West Nile Virus and Other Arboviruses.
Vanichanan J, Salazar L, Wootton SH, Aguilera E, Garcia MN, Murray KO, Hasbun R. Vanichanan J, et al. Emerg Infect Dis. 2016 Sep;22(9):1587-93. doi: 10.3201/eid2209.152050. Emerg Infect Dis. 2016. PMID: 27537988 Free PMC article. - Immunoinformatics and molecular dynamics approaches: Next generation vaccine design against West Nile virus.
Khan MT, Islam R, Jerin TJ, Mahmud A, Khatun S, Kobir A, Islam MN, Akter A, Mondal SI. Khan MT, et al. PLoS One. 2021 Jun 17;16(6):e0253393. doi: 10.1371/journal.pone.0253393. eCollection 2021. PLoS One. 2021. PMID: 34138958 Free PMC article. - A Rare Case of Neuroinvasive West Nile Virus in Florida Presenting As Guillain Barré Syndrome.
Sciturro M, Rehl S, Klingensmith J. Sciturro M, et al. Cureus. 2022 Dec 30;14(12):e33138. doi: 10.7759/cureus.33138. eCollection 2022 Dec. Cureus. 2022. PMID: 36721565 Free PMC article. - Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function.
Spiteri AG, Wishart CL, Pamphlett R, Locatelli G, King NJC. Spiteri AG, et al. Acta Neuropathol. 2022 Feb;143(2):179-224. doi: 10.1007/s00401-021-02384-2. Epub 2021 Dec 1. Acta Neuropathol. 2022. PMID: 34853891 Free PMC article. Review.
References
- Nash D, Mostashari F, Fine A, Miller J, O’Leary D, et al. (2001) The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344: 1807–1814. - PubMed
- Carson PJ, Konewko P, Wold KS, Mariani P, Goli S, et al. (2006) Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis 43: 723–730. - PubMed
- Gottfried K, Quinn R, Jones T (2005) Clinical description and follow-up investigation of human West Nile virus cases. South Med J 98: 603–606. - PubMed
Publication types
MeSH terms
Grants and funding
- 266200500027C/PHS HHS/United States
- AI U19 089992/AI/NIAID NIH HHS/United States
- 5R01AI091816-01/AI/NIAID NIH HHS/United States
- N01 50027/PHS HHS/United States
- R01 AI091816/AI/NIAID NIH HHS/United States
- K23 AI057341/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical